EXPERT SUMMARIES of the top 30 journals in endocrinology
 Personalize your search
In the Journals Plus

GLP-1 agonists reduce risks for CV, all-cause mortality in type 2 diabetes

Perrone-Filardi P, et al. Nutr Metab Cardiovasc Dis. 2017;doi:10.1016/j.numecd.2017.09.006.
A recently published meta-analysis found that GLP-1 agonists substantially reduced both cardiovascular and all-cause mortality in patients with type
In the Journals Plus

Short-term probiotic supplementation may aid weight loss

Borgeraas H, et al. Obes Rev. 2017;doi:10.1111/obr.12626.
Adults with overweight or obesity who used a probiotic supplement experienced greater reductions in weight, BMI, fat mass and fat percentage compared…
In the Journals Plus

Lenvatinib effective for differentiated thyroid cancer despite adverse effects

Amandine B, et al. Thyroid. 2017;doi:10.1089/thy.2017.0205.
The use of lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer in adults was relatively effective, but adverse…
In the Journals PlusPerspective

SCALE: Liraglutide increases health-related quality of life in obesity, prediabetes

Kolotkin RL, et al. Clin Obes. 2017;doi:10.1111/cob.12226.
Adults with obesity and prediabetes showed 3-year improvements in health-related quality of life and weight loss with once-daily subcutaneous…
In the Journals Plus

Long-acting pasireotide safe, effective for recurrent Cushing’s disease

Lacroix A, et al. Lancet Diabetes Endocrinol. 2017;doi:10.1016/s2213-8587(17)30326-1.
In patients with persistent or recurring Cushing’s disease after surgery, monthly pasireotide was safe and effective, leading to normal urinary…
In the Journals Plus

Brain glucose levels diminished in obesity, type 2 diabetes during hyperglycemia

Hwang JJ, et al. JCI Insight. 2017;doi:10.1172/jci.insight.95913.
Adults with obesity or poorly controlled type 2 diabetes have decreased intracerebral glucose levels that can lead to adverse neurocognitive…
In the Journals PlusPerspective

Commercial weight-management program effective for diabetes prevention

Piper C, et al. BMJ Open Diabetes Res Care. 2017;doi:10.1136/bmjdrc-2017-000418.
Adults at high risk for type 2 diabetes may successfully reduce that risk — and their body weight — when participating in a diabetes…
In the Journals Plus

Prolactinoma increases CVD risk in men

Toulis KA, et al. Clin Endocrinol. 2017;doi:10.1111/cen.13498.
Men with prolactinoma are at higher risk for incident cardiovascular disease compared with women with prolactinoma and healthy men and women…
In the Journals Plus

Consensus statement: Diabetes language matters

Dickinson JK, et al. Diabetes Care. 2017;doi:10.2337/dci17-0041.
Health care providers should employ neutral, nonjudgmental language that puts a patient with diabetes before the disease to remove pervasive…
In the Journals Plus

Adverse event reports of acute renal failure more numerous with SGLT2 inhibitors vs other agents

Perlman A, et al. Nutr Metab Cardiovasc Dis. 2017;doi:10.1016/j.numecd.2017.10.011.
Compared with other diabetes medications, SGLT2 inhibitors were associated with more reports of acute renal failure in the FDA adverse event report…
In the Journals Plus

Favorable outcomes seen for lung-only metastatic thyroid cancer

Sohn SY, et al. Clin Endocrinol. 2017;doi:10.1111/cen.13489.
Results of a retrospective study conducted in South Korea demonstrated that most patients with metastatic differentiated thyroid cancer confined to
In the Journals Plus

Gestational diabetes often leads to poor metabolic health in offspring

Grunnet LG, et al. Diabetes Care. 2017;doi:10.2337/dc17-0514.
Children of mothers who had gestational diabetes are more likely to have increased adiposity, an adverse cardiometabolic profile and early onset of…
In the Journals Plus

Statin therapy increases risk for incident diabetes in high-risk adults

Crandall JP, et al. BMJ Open Diabetes Res Care. 2017;doi:10.1136/bmjdrc-2017-000438.
Adults with prediabetes who participated in the Diabetes Prevention Program Outcomes Study were more likely to develop incident type 2 diabetes if…
In the Journals Plus

Neurodevelopment unaffected by maternal iodine supplementation

Bath SC. Lancet Diabetes Endocrinol. 2017;doi:10.1016/s2213-8587(17)30331-5.
Gowachirapant S, et al. Lancet Diabetes Endocrinol. 2017;doi:10.1016/s2213-8587(17)30332-7.
In iodine-deficient pregnant women, supplementation with daily oral iodine did not affect the neurodevelopment of offspring at age 5 to 6 years…
In the Journals PlusPerspective

Malignant thyroid nodules grow faster than benign nodules

Angell TE, et al. J Clin Endocrinol Metab. 2017;doi:10.1210/jc.2017-01832.
Malignant thyroid nodules are more likely to grow at least 2 mm per year and increase in volume compared with benign thyroid nodules, according to…

Personalize your search